Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
ISIS-GCCRRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
ISIS-GCGRRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes
1 trial -
ISIS-GCGRRx - Dose Level 1
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
ISIS-GCGRRx- Dose Level 1
IONIS PHARMACEUTICALS INC
Type 2 Diabetes
1 trial -
ISIS-PTP1BRx
IONIS PHARMACEUTICALS INC
Type 2 Diabetes Mellitus
1 trial -
IW-1973
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
IW-1973
Akebia Europe Limited
Type 2 Diabetes Mellitus With Diabetic Nephropathy
1 trial -
IW-9179
IRONWOOD PHARMACEUTICALS INC
Diabetic Gastroparesis
1 trial -
Iberdomide, Iberdomide, Cevostamab, Iberdomide, Revlimid 10 mg hard capsules, RoActemra 20 mg/mL concentrate for solution for infusion, Iberdomide, Revlimid 5 mg hard capsules
Hoffmann-La Roche
Multiple Myeloma (MM)
1 trial -
Iberdomide, Iberdomide, Etentamig, Iberdomide, Iberdomide
AbbVie Deutschland GmbH & Co. KG
Multiple Myeloma
1 trial -
Iberdomide, Iberdomide, Iberdomide, Iberdomide, Dexamethasone Tablets BP 2.0mg, Iberdomide, Iberdomide, Iberdomide, Dexamethasone 2mg Tablets , Iberdomide, Iberdomide, DARZALEX 1800 mg solution for injection, Iberdomide, Iberdomide, Iberdomide, Dexamethason-ratiopharm® 4 mg Tabletten
Celgene Europe Limited
Multiple Myeloma
1 trial -
Ibrutinib
United Therapeutics Europe Ltd
Asymptomatic COVID-19 Infection Laboratory-Confirmed
1 trial -
Ibrutinib, IMBRUVICA 140 mg film-coated tablets, Ibrutinib, Prednison acis 5 mg, Tabletten, Prednison acis 20 mg, Tabletten, Ibrutinib, Prednison acis 50 mg, Tabletten
AbbVie Deutschland GmbH & Co. KG
Chronic Graft Versus Host Disease (cGVHD)
1 trial -
Iclusig 15 mg film-coated tablets
Ningbo Cancer Hospital
Chronic myelogenous leukemia
1 trial -
Iclusig 15 mg film-coated tablets, BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion., Imatinib TAD 400 mg επικαλυμμένα με λεπτό υμένιο δισκία
Cardiff Oncology
Blood cancer
1 trial -
Iclusig 15 mg film-coated tablets, Iclusig 45 mg film-coated tablets, Ponatinib, Iclusig 15 mg film-coated tablets, Iclusig 15 mg film-coated tablets, Iclusig 30 mg film-coated tablets., Ponatinib, Iclusig 45 mg film-coated tablets, Ponatinib
Incyte
Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors
1 trial -
Iclusig 30 mg film-coated tablets, Iclusig 45 mg film-coated tablets, Iclusig 45 mg film-coated tablets, Iclusig 15 mg film-coated tablets, Iclusig 15 mg film-coated tablets, Iclusig 15 mg film-coated tablets, Ponatinib
Takeda
Chronic Phase Chronic Myeloid Leukemia
1 trial -
Ifinatamab Deruxtecan
Merck Sharp and Dohme
Esophageal squamous cell carcinoma
1 trial -
Ifinatamab Deruxtecan, DOCETAXEL , Raludotatug Deruxtecan
Merck Sharp and Dohme
Non-small Cell Lung Cancer
1 trial -
Ifinatamab deruxtecan
Daiichi Sankyo
Recurrent or Metastatic Solid Tumors (endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcinoma (HCC); adenocarcinoma of esophagus, gastroesophageal junction, and stomach (Ad-Eso/GEJ/gastric); urothelial carcinoma (UC); ovarian cancer (OVC); cervical cancer (CC); biliary tract cancer (BTC); human epidermal growth factor 2 (HER2)-low breast cancer (BC); HER2 immunohistochemistry (IHC) 0 BC; and cutaneous melanoma)
1 trial -
Ifinatamab deruxtecan
Daiichi Sankyo
Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC)
1 trial -
Imdusiran (AB-729)
Arbutus Biopharma Corp
Chronic Hepatitis B
1 trial -
Imdusiran, IMFINZI 50 mg/mL concentrate for solution for infusion.
Arbutus Biopharma Corp
Chronic HBV Infection
1 trial -
Imgatuzumab
Centessa Pharmaceuticals plc
Cutaneous Squamous Cell Carcinoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources